Clinical Trials Directory

Trials / Unknown

UnknownNCT06202430

Ultrasound Guided Block for Postoperative Analgesia in Arthroscopic Shoulder Surgery

Comparison of Ultrasound Guided High Thoracic Erector Spinae Plane Block With Shoulder Block for Postoperative Analgesia in Arthroscopic Shoulder Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study aimed to compare the efficacy of high thoracic-ESPB with shoulder block as analgesic options for arthroscopic shoulder surgery. Primary outcome: • 24-hour analgesic consumption. Secondary outcomes: * Postoperative pain evaluated by: Visual Analogue Pain Scale (VAS). * Time to first rescue analgesia and total postoperative consumption of analgesia. * Effect of the block on Hemodynamics. * Adverse effects in the form of postoperative nausea and vomiting (PONV). * Patient satisfaction.

Conditions

Interventions

TypeNameDescription
PROCEDUREHigh Thoracic Erector Spinae Plane BlockHigh Thoracic-ESPB The patient was placed in the lateral decubitus. The transverse process of T2 was identified. After negative aspiration, hydro dissection using 2 mL of saline was performed. Eventually, 30 mL of the LA bupivacaine 0.25% and epinephrine 5 µg/ mL was injected.
PROCEDUREShoulder BlockShoulder Block Suprascapular nerve block (SSNB) approach: The needle was progressed in plane from medial to lateral after local infiltration of the skin with 1% lidocaine. We directed the needle towards the lateral side of the supra-spinous fossa if the neuro-vascular bundle was not evident. After careful aspiration, 10 ml of 0.5% bupivacaine was injected under the supraspinatus muscle. Axillary nerve block technique: The nerve approach had been described in plane from cranial to caudal. After local infiltration of the skin with 1% lidocaine, the needle tip must be visualized within the fascia below the teres minor muscle and just above the PCHA. After cautious aspiration, 10 ml of 0.5% bupivacaine was injected on the posterior aspect of the humerus.

Timeline

Start date
2023-08-13
Primary completion
2024-01-14
Completion
2024-01-14
First posted
2024-01-11
Last updated
2024-01-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06202430. Inclusion in this directory is not an endorsement.